NCT00415129 Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly Status COMPLETED Phase PHASE2
NCT00412737 A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants Status COMPLETED Phase PHASE4
NCT00412555 A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children. Status COMPLETED Phase PHASE4
NCT00410176 A Randomized, Controlled, Unblinded, Clinical Trial of the Acceptability and Efficacy of Non-Pharmaceutical Methods in Preventing Spread of Influenza Within the Family Status UNKNOWN Phase NA
NCT00408395 Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children Status COMPLETED Phase PHASE2
NCT00404664 Improving Influenza Vaccination Rates Among Health Care Professionals Status COMPLETED Phase NA
NCT00402649 Open-Label Study of H5 Vaccine in Participants of Protocol 04-077 Status COMPLETED Phase PHASE1/PHASE2
NCT00397215 Evaluate Safety & Immunogenicity of a Pandemic Influenza Vaccine (GSK1562902A) in Adults Over 60 Years of Age Status COMPLETED Phase PHASE2
NCT00395174 Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults Status COMPLETED Phase PHASE3
NCT00391768 Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza Status COMPLETED Phase PHASE1/PHASE2
NCT00391391 Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children Status COMPLETED Phase PHASE2
NCT00391053 Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly Status COMPLETED Phase PHASE3
NCT00390884 Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. Status COMPLETED Phase PHASE4
NCT00389857 Trial to Collect Safety Data and Sera for Immunogenicity Testing Status COMPLETED Phase PHASE4
NCT00389532 Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine Status COMPLETED Phase PHASE4
NCT00388583 Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects Status COMPLETED Phase PHASE2
NCT00386698 Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults Status COMPLETED Phase PHASE2
NCT00386542 Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children Status COMPLETED Phase PHASE1/PHASE2